Literature DB >> 8997557

Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in The Netherlands.

A A van Zwet1, W A de Boer, P M Schneeberger, J Weel, A R Jansz, J C Thijs.   

Abstract

The minimum inhibitory concentrations of metronidazole and clarithromycin were determined for 780 Helicobacter pylori strains collected in 1994 and 1995 from three different regions in The Netherlands. The overall prevalence of primary metronidazole resistance was 17%, with resistance found more frequently in women (24%) than in men (13%). There was no significant difference between the levels of resistance in the three regions. Primary clarithromycin resistance was rare (1%) and relatively infrequent as compared to that found in other countries. Four of the six strains resistant to clarithromycin were also resistant to metronidazole.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8997557     DOI: 10.1007/bf01691216

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  20 in total

Review 1.  A reliable cure for Helicobacter pylori infection?

Authors:  D Y Graham
Journal:  Gut       Date:  1995-07       Impact factor: 23.059

Review 2.  Practical diagnosis of Helicobacter pylori infection.

Authors:  A A van Zwet; J C Thijs; R Roosendaal; E J Kuipers; S Peña; J de Graaff
Journal:  Eur J Gastroenterol Hepatol       Date:  1996-05       Impact factor: 2.566

Review 3.  Helicobacter pylori: the place of the new macrolides in the eradication of the bacteria in peptic ulcer disease.

Authors:  A Burette; Y Glupczynski
Journal:  Infection       Date:  1995       Impact factor: 3.553

Review 4.  In vitro susceptibility testing of Helicobacter pylori to antimicrobial agents: basis for treatment or microbiologists' obsession?

Authors:  Y Glupczynski
Journal:  Zentralbl Bakteriol       Date:  1993-09

5.  Short report: clarithromycin, an alternative to metronidazole in the triple therapy of Helicobacter pylori infection.

Authors:  J C Thijs; A A Van Zwet; W Moolenaar; J A Oom; H De Korte; E A Runhaar
Journal:  Aliment Pharmacol Ther       Date:  1994-02       Impact factor: 8.171

6.  Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial.

Authors:  W L Peterson; D Y Graham; B Marshall; M J Blaser; R M Genta; P D Klein; C W Stratton; J Drnec; P Prokocimer; N Siepman
Journal:  Am J Gastroenterol       Date:  1993-11       Impact factor: 10.864

7.  Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori.

Authors:  J Versalovic; D Shortridge; K Kibler; M V Griffy; J Beyer; R K Flamm; S K Tanaka; D Y Graham; M F Go
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

8.  Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection.

Authors:  M T al-Assi; F C Ramirez; G M Lew; R M Genta; D Y Graham
Journal:  Am J Gastroenterol       Date:  1994-08       Impact factor: 10.864

9.  Randomized study comparing 1 with 2 weeks of quadruple therapy for eradicating Helicobacter pylori.

Authors:  W A de Boer; W M Driessen; V P Potters; G N Tytgat
Journal:  Am J Gastroenterol       Date:  1994-11       Impact factor: 10.864

10.  The E test for antimicrobial susceptibility testing of Helicobacter pylori.

Authors:  G Cederbrant; G Kahlmeter; A Ljungh
Journal:  J Antimicrob Chemother       Date:  1993-01       Impact factor: 5.790

View more
  16 in total

1.  Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan.

Authors:  M Kato; Y Yamaoka; J J Kim; R Reddy; M Asaka; K Kashima; M S Osato; F A El-Zaatari; D Y Graham; D H Kwon
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

2.  Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in Singapore.

Authors:  Jie-Song Hua; Ho Bow; Peng-Yuan Zheng; Yeoh Khay-Guan
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

3.  Clarithromycin resistance in Helicobacter pylori and its clinical relevance.

Authors:  Hua-Xiang Xia; Xue-Gong Fan; Nicholas J Talley
Journal:  World J Gastroenterol       Date:  1999-06       Impact factor: 5.742

4.  Antibiotic susceptibility of Helicobacter pylori clinical isolates: comparative evaluation of disk-diffusion and E-test methods.

Authors:  K K Mishra; S Srivastava; A Garg; A Ayyagari
Journal:  Curr Microbiol       Date:  2006-09-12       Impact factor: 2.188

5.  Helicobacter pylori specific nested PCR assay for the detection of 23S rRNA mutation associated with clarithromycin resistance.

Authors:  S Maeda; H Yoshida; K Ogura; F Kanai; Y Shiratori; M Omata
Journal:  Gut       Date:  1998-09       Impact factor: 23.059

6.  Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study.

Authors:  L J van Doorn; Y Glupczynski; J G Kusters; F Mégraud; P Midolo; N Maggi-Solcà; D M Queiroz; N Nouhan; E Stet; W G Quint
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

7.  Detection of clarithromycin-resistant helicobacter pylori strains by a preferential homoduplex formation assay.

Authors:  S Maeda; H Yoshida; H Matsunaga; K Ogura; O Kawamata; Y Shiratori; M Omata
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

8.  Rapid detection, by PCR and reverse hybridization, of mutations in the Helicobacter pylori 23S rRNA gene, associated with macrolide resistance.

Authors:  L J van Doorn; Y J Debets-Ossenkopp; A Marais; R Sanna; F Mégraud; J G Kusters; W G Quint
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

9.  Antibiotic resistance and antibiotic sensitivity based treatment in Helicobacter pylori infection: advantages and outcome.

Authors:  M E Street; P Caruana; C Caffarelli; W Magliani; M Manfredi; F Fornaroli; G L de'Angelis
Journal:  Arch Dis Child       Date:  2001-05       Impact factor: 3.791

10.  Rapid increase in the prevalence of metronidazole-resistant Helicobacter pylori in the Netherlands.

Authors:  E J van der Wouden; A A van Zwet; G D Vosmaer; J A Oom; A de Jong; J H Kleibeuker
Journal:  Emerg Infect Dis       Date:  1997 Jul-Sep       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.